Form 4: Beta Bionics CEO Sean Saint Acquires Shares and Options in Company
SEC Form 4 Filing
Sean Saint, President & CEO of Beta Bionics, acquired 108,000 shares of common stock and options to purchase 163,000 shares on February 27, 2025.
Summary
- On February 27, 2025, Sean Saint, the President & CEO of Beta Bionics, acquired 108,000 shares of common stock.
- These shares were obtained through a restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
- Additionally, Saint acquired options to purchase 163,000 shares of common stock at an exercise price of $19.91.
- The options vest in 36 equal monthly installments starting from February 27, 2025, and expire on February 26, 2035.
- Following these transactions, Saint directly owns 108,000 shares of common stock and options for 163,000 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The CEO's acquisition could be interpreted as slightly positive, indicating confidence, but it's not overtly bullish.
Positives
- The CEO's acquisition of shares and options could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the options suggests a multi-year commitment from the CEO.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the alignment of management's interests with those of shareholders.
Stakeholder Impact
- The CEO's increased stake in the company could potentially align his interests more closely with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 02/27/2025 | Start date for vesting of stock options in 36 equal monthly installments. |
| 02/26/2035 | Expiration date of the acquired stock options. |
| 03/03/2025 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.